Serologicals Corporation Reports First Quarter Results

ATLANTA--(BUSINESS WIRE)--April 26, 2006--Serologicals Corporation (NASDAQ: SERO - News) announced today its financial results for the first quarter ended April 2, 2006. Revenues decreased 2.8%, to $55.0 million, compared to $56.6 million in the same period last year. Diluted earnings per share increased 52.8% to $0.08 per share compared to $0.05 per share in the same period in the prior year. The decrease in revenues was primarily due to the divestiture of certain Bioprocessing product lines previously manufactured at our former facility in Milford, MA, which was sold in January 2006. The decrease was partially offset by increased revenues in the Research segment.